Delivery Order SPE2DR25D1017-SPE2DR26F9BDF
- Not listed
- The Defense Logistics Agency awarded a $2,419.93 delivery order to AmerisourceBergen Drug Corp on June 16, 2025, for the supply of Mounjaro 15 mg/0.5 mL pens. This competitively awarded, firm fixed-price contract with an ultimate completion date of June 17, 2025 will be fulfilled from the vendor's Conshohocken, Pennsylvania facility. The delivery order represents a child contract under AmerisourceBergen's broader pharmaceutical supply relationship with the federal government. This delivery order...
- The Defense Logistics Agency awarded a $8,690.90 delivery order to AmerisourceBergen Drug Corp on December 3, 2025, for the supply of Mounjaro 5 mg/0.5 mL pens. This competitively awarded, firm fixed-price contract carries an ultimate completion date of December 4, 2025, and will be fulfilled from AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The award represents a child order under a larger contract vehicle, leveraging the company's established relationship with the...
- The Defense Logistics Agency awarded a delivery order valued at $3,549.34 to AmerisourceBergen Drug Corp for the supply of Mounjaro 15 mg/0.5 mL pens on November 25, 2025, with completion targeted for November 26, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends...
- The Defense Logistics Agency awarded a Delivery Order valued at $5,789.98 to AmerisourceBergen Drug Corp for the supply of Mounjaro 10 mg/0.5 mL pens on November 17, 2025, with completion expected by November 18, 2025. This firm fixed-price, non-competitive delivery order represents a continuation of AmerisourceBergen's role as a critical pharmaceutical supplier to the federal government. The product will be delivered to the company's facility in Conshohocken, Pennsylvania, where...
- The Defense Logistics Agency awarded a $2,776.41 delivery order to AmerisourceBergen Drug Corp for the supply of Mounjaro 5 mg/0.5 mL pens on September 22, 2025, with completion targeted for September 23, 2025. This is a firm fixed price, non-set-aside contract with performance taking place at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at...
- The Defense Logistics Agency awarded a delivery order valued at $1,005.80 to AmerisourceBergen Drug Corp for Mounjaro 7.5 mg/0.5 ml pen (0.5 ml), a diabetes medication. The award, issued on December 4, 2025, with an ultimate completion date of December 5, 2025, represents a firm fixed-price delivery order with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is the place of performance for this order. As a major pharmaceutical distributor and critical...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $2,176.72 for Mounjaro 10 mg/0.5 ml pen (0.5ml) on July 29, 2025, with an ultimate completion date of July 30, 2025. This firm fixed price, non-set-aside contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a single transaction for this diabetes medication under a larger contract vehicle. This award is a child delivery...
- The Defense Logistics Agency awarded a delivery order valued at $2,959.30 to AmerisourceBergen Drug Corp for Mounjaro 5 mg/0.5 mL pens on December 2, 2025, with an ultimate completion date of December 3, 2025. This competitive award, which carries no set-aside designation, represents a firm fixed-price delivery order for the diabetes medication to support federal healthcare needs. The pharmaceutical distributor, headquartered in Conshohocken, Pennsylvania, will perform this delivery at its...
- The Defense Logistics Agency has awarded a delivery order valued at $1,981.83 to AmerisourceBergen Drug Corp for the supply of Mounjaro 10 mg/0.5 mL pen injectables. This is a firm fixed price, non-set-aside delivery order with an ultimate completion date of November 4, 2025, and represents a child contract under AmerisourceBergen's larger indefinite delivery contract vehicle with DLA. The pharmaceutical product will be delivered to the company's headquarters location in Conshohocken,...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $26,637.01 on December 1, 2025, for the supply of Mounjaro 5 mg/0.5 ml pen injectors. This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of December 2, 2025. The contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at...
- SPE2DR25D1017Indefinite Delivery Contract
- SPE2DR25D1017-SPE2DR26F9BDFDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $4,054.86 to AmerisourceBergen Drug Corp for the supply of Mounjaro 5 mg/0.5 mL pens on December 9, 2025, with completion scheduled for December 10, 2025. This competitive award, utilizing firm fixed pricing with no set-aside designation, represents a single delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX). The contract will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order falls within AmerisourceBergen's comprehensive pharmaceutical supply agreement valued at $999,999,999.00 through December 2026, which serves as a global pharmaceutical support vehicle enabling the company to supply military healthcare programs worldwide. As a major pharmaceutical distributor, AmerisourceBergen supplies an extensive portfolio of medications and medical supplies to federal healthcare systems, including the Defense Health Agency and U.S. Coast Guard. The award of this diabetes medication reflects the company's role in supporting the medical supply chain for defense and military healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.1k | 12/8/25 |